戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              DD achieved a remission rate (RR) of 64% and a very good
2                                              DD offers a convenient alternative approach to BMD metho
3                                              DD represents an ideal human model disease for fibrosis
4                                              DD therapy also further downregulated BALF ILs and cytok
5                                              DD was considered negative (DD-) if <500 ng/mL.
6                                              DD, but not VD, MNs reverse their cellular polarity in a
7                                              DD-study: Diet or Diuretics for Salt-sensitivity in Chro
8 for ruling out AAS in patients with ADD-RS=0/DD- or ADD-RS </=1/DD-.
9                In 294 patients with ADD-RS=0/DD-, 1 case of AAS was observed.
10              Improvement in DD grade/grade 1 DD at 30 days post-TAVR was seen in 70.8% patients.
11              Improvement in DD grade/grade 1 DD at 30 days was protective for 1-year CV death/rehospi
12  with improvement in >=1 grade of DD/grade 1 DD had reduced 1-year CV death/rehospitalization (p < 0.
13  the 1,750 included, 682 (54.4%) had grade 1 DD, 352 (28.1%) had grade 2 DD, 168 (13.4%) had grade 3
14 9.9% (95% CI, 47.7-52.2) for the ADD-RS </=1/DD- strategy.
15             In 924 patients with ADD-RS </=1/DD-, 3 cases of AAS were observed.
16 in patients with ADD-RS=0/DD- or ADD-RS </=1/DD-.
17 35 subjects with first-episode psychosis (11 DD, 12 SZ, 12 other psychotic disorders) and 19 healthy
18 m June 2013 to June 2015, we identified 1768 DD livers exported to regional candidates with MELD scor
19 .4%) had grade 1 DD, 352 (28.1%) had grade 2 DD, 168 (13.4%) had grade 3 DD, and 51 (4.1%) had indete
20                             Baseline grade 3 DD was a predictor of 1-year CV death/rehospitalization
21 .1%) had grade 2 DD, 168 (13.4%) had grade 3 DD, and 51 (4.1%) had indeterminate DD grade.
22 Common Terminology Criteria [CTC] grade 3/4: DD 16%, DVD 18%) and likely related to a high rate of ly
23 high rate of lymphocytopenia (CTC grade 3/4: DD 20%, DVD 17%).
24 iable method of producing cultures of >/=90% DD Mtb in starved cells.
25 P until a candidate is eligible to receive a DD-CIK.
26 tude lower than that of the corresponding AA.DD duplex.
27 ion is observed for homo-sequence 2-mers (AA.DD) where there are no competing folding equilibria.
28 e for Paired Kidney Donation, and the actual DDs from the Scientific Registry of Transplant Recipient
29 e Statistics database and included all adult DD patients who were surgically treated.
30 ystemic complications and re-operation after DD surgery.
31                       On restarting SD after DD treatment, a possible carryover effect was seen for s
32  as: deceased-donor kidney transplant alone (DD-KA, 68%), living-donor kidney transplant alone (LD-KA
33  ROR: 2.24, 95% CI: 1.09-4.61, p = 0.029 and DD = +9.1 pp, ROR: 2.65, 95% CI: 1.01-6.98, p = 0.048) a
34 polysorbate 80 levels were tested by BMD and DD.
35  TP53+/+ cells compared to TP53-/- cells and DD-Cas9, suggesting that differences in break sensing ar
36                                 With EVD and DD, a specific clinicopathologic diagnosis was made in 2
37 opsy specimens examined in 2015 with EVD and DD.
38 lized panels; Sensititre; Thermo Fisher) and DD (30 mug; research-use-only [RUO] MASTDISCS and FDA-cl
39 d of high energy lipid classes, while HD and DD tissues contained greater proportions of structural l
40 d possible homology, between hippocampal and DD/DL circuitry.
41  16 individuals with mild to profound ID and DD and a de novo mutation in PPP2CA, encoding the cataly
42 were tested as comparator agents for MIC and DD methods, respectively.
43 ives as aromatic C(sp(2))-H nucleophiles and DDs as acceptors.
44 cts were categorized into +DD ( n = 29) and -DD ( n = 18) groups.
45 thophysiology of psychotic disorders such as DD and SZ.
46 R); and two non-arginyl dipeptides: Asp-Asp (DD) and Glu-Asp (ED).
47 een Fas death domain (DD) and Fas-associated DD (FADD).
48 In the PARTNER 2 SAPIEN 3 registry, baseline DD was a predictor of up to 2 years clinical outcomes in
49           We describe the connection between DD and global assortativity of the network from both for
50 peripherally NBN-doped PAHs to form H-bonded DD.AA- and ADDA.DAAD-type complexes with suitable comple
51 binding studies of the first double-H-bonded DD.AA-type complexes of a series of aromatic boronic aci
52                                         Both DD methods performed poorly for Acinetobacter baumannii
53 es were susceptible by Etest, 70% (67/96) by DD, and 88% (84/96) by agar dilution.
54                                We calculated DD prevalence for each definition and determined the ove
55                                    Cefoxitin DD performed best when interpreted with the CLSI SOSA br
56        Likewise, oxacillin BMD and cefoxitin DD tests using the coagulase-negative Staphylococcus spe
57 . schleiferi and oxacillin BMD and cefoxitin DD tests using the CoNS breakpoints reliably identified
58                                For cefoxitin DD and BMD results interpreted using S. aureus/S. lugdun
59           There were 4.9% VMEs for cefoxitin DD with 0% MEs, and 3.6% VMEs and 3.9% MEs for cefoxitin
60 connections between land cover and childhood DD, we compiled a database of 293,362 children in 35 cou
61 ier to seeking healthcare for sick children (DD = -26.4 pp, ROR: 0.23, 95% CI: 0.08-0.66, p = 0.006).
62 e "low-cost" tools to evaluate DD-a clinical DD score, the balloon expulsion test (BET) and a digital
63 , constipated patients answered the clinical DD score and were evaluated by DRE and BET [standard and
64                                 The clinical DD score revealed an AUC of 0.417 (SE = 0.07, p = 0.191)
65 ry) to diseased tissue on diseased colonies (DD; i.e. lesion front) was observed, demonstrating a red
66                      Under these conditions, DD and DH were 39.40 and 2.11%, respectively.
67                                        DAPK1-DD-deficient mice were more susceptible to tumor growth
68 , which are essential for constant darkness (DD) rhythmicity.
69 ed on reaching a high degree of deamidation (DD) with a simultaneously low degree of hydrolysis (DH).
70  ; LD-KA: aHR (1.29) 1.87(2.71) ) and death (DD-KA: aHR (2.12) 3.25(5.00) ; LD-KA: aHR (1.54) 2.35(3.
71 concentration of trans,trans-2,4-decadienal (DD) during the light cycle.
72 tual disability (ID) or developmental delay (DD) and short stature.
73 ldren with ASD (N=415), developmental delay (DD) without ASD (N=188), and general population (GP) con
74 ual disability (ID) and developmental delay (DD).
75 ess than that of the unmodified drug depots (DDs).
76 tagonist SFRP4, in surgical specimen-derived DD myofibroblasts.
77 generating such "differentially detectable" (DD) Mtb in vitro would aid studies of the biology and dr
78  receiving either daratumumab/dexamethasone (DD, n = 106) or daratumumab/bortezomib/dexamethasone (DV
79 2 and two degradation domains (FKBP-DD, DHFR-DD), in multiple orientations, and determined (i) the fo
80 e measured the vertical optic disc diameter (DD) of the UK Biobank (UKBB) cohort (N = 67 040) and per
81 calization, and overexpression of a Dia1 DID-DD fragment competitively removed Dia1 and Dia2 from cel
82                                  In Dia1 DID-DD-overexpressing cells, Dia1 and Dia2 were mislocalized
83 s inhibitory domain-dimerization domain (DID-DD) region of Dia1 was sufficient for Dia1 localization,
84 itions of indoles with 1,2-diaza-1,3-dienes (DDs) is reported.
85 ent of resorcinols and 1,2-diaza-1,3-dienes (DDs) under acidic conditions.
86 othioamides (ATAs) and 1,2-diaza-1,3-dienes (DDs).
87  underexplored measure, 'degree difference' (DD) between vertices of an edge, to understand the local
88                   Difference-in-differences (DD) estimates of impact were calculated, adjusting for c
89              Typically, edges with different DD play different structural roles and the DD distributi
90 uate oxacillin and cefoxitin disk diffusion (DD) and broth microdilution (BMD) methods for the detect
91 omycin Etest and Kirby-Bauer disk diffusion (DD) assays, and the results were compared to those obtai
92 n broth microdilution (BMD), disk diffusion (DD), and PBP2a immunoassay, and the results were compare
93                                     D-dimer (DD) is highly sensitive for AAS but is inadequate as a s
94 and patients grouped by this and by D-dimer (DD) levels.
95  classes of photoproducts-dibenzo-p-dioxins (DDs) and 2,2'-dihydroxylated biphenyls-was also investig
96 lopmental delay and intellectual disability (DD and ID) are heterogeneous phenotypes that arise in ma
97 mental delay and/or intellectual disability (DD and/or ID) disease phenotypes.
98                           Delay discounting (DD), the tendency to discount the value of delayed versu
99                      Moreover, we discovered DD-03-171, an optimized lead compound that exhibits enha
100          Individuals with Dupuytren disease (DD) are commonly seen by physicians and surgeons across
101  Salt-sensitivity in Chronic Kidney Disease (DD), NCT02875886.
102                         Dupuytren's disease (DD) is a common fibro-proliferative disorder of the palm
103 ssue from patients with Dupuytren's disease (DD), a localized fibrotic disorder of the palm, we sough
104                       A defecation disorder (DD) is a difficulty in evacuation documented by physiolo
105 chosis, such as between delusional disorder (DD) and schizophrenia (SZ).
106 on binding, as well as disorder-to-disorder (DD) transitions, when the conformational heterogeneity i
107 ole of RT in severe developmental disorders (DD) has not yet been explored.
108                        Depressive disorders (DDs), anxiety disorders (ADs), obsessive-compulsive diso
109  7833 probands with developmental disorders (DDs) and their unaffected parents, as well as more than
110 ne individuals with developmental disorders (DDs).
111 g (MODY) and severe developmental disorders (DDs).
112 oromandibular joint (TMJ) disc displacement (DD) and degenerative joint disease (DJD) has never been
113 without (-) bilateral TMJ disc displacement (DD).
114 tative progenitors, Brachypodium distachyon (DD) and Brachypodium stacei (SS).
115  to the interphase between Fas death domain (DD) and Fas-associated DD (FADD).
116 is and cell death that recruit death domain (DD) proteins FADD and TRADD and caspases to form death-i
117                     RIPK1 is a death-domain (DD) containing kinase involved in regulating apoptosis,
118 ll molecule by using a destabilizing domain (DD).
119    In this study, the module docking domain (DD) affinity prediction performance on a hold-out testin
120 ely diagnostic de novo mutations in dominant DD-associated genes at noncanonical positions in splice
121 ocation system that includes deceased donor (DD) kidneys as chain-initiating kidneys (DD-CIK) in a ki
122              Under Share 35, deceased donor (DD) livers are offered regionally to candidates with Mod
123 malizing AAT trough levels with double-dose (DD) therapy (120 mg/kg/wk) in subjects with AATD already
124  Ex vivo dermoscopy (EVD) with derm dotting (DD) improves clinicopathologic correlation and the quali
125 e association between diastolic dysfunction (DD) and outcomes in patients with aortic stenosis underg
126                       Diastolic dysfunction (DD) is an independent predictor of HFpEF risk, associate
127 left ventricular (LV) diastolic dysfunction (DD), with 25% exhibiting grade III/IV restrictive DD wit
128  is often preceded by diastolic dysfunction (DD).
129                      Developmental dyslexia (DD) is a learning disorder affecting the ability to read
130  of eight cases with developmental dyslexia (DD) revealed several regions shared by the affected indi
131 nto the American Society of Echocardiography DD groups.
132  whereas no effect was observed with RE, ER, DD, or ED.
133           Three "low-cost" tools to evaluate DD-a clinical DD score, the balloon expulsion test (BET)
134 her odds of delivering in a health facility (DD = +10.6 pp, ROR: 1.53, 95% CI: 1.10-2.13, p = 0.012)
135 tly higher risk of kidney allograft failure (DD-KA: aHR (1.53) 2.20(3.17) ; LD-KA: aHR (1.29) 1.87(2.
136 flurane hindered the interaction between Fas DD and FADD.
137 e is known to play a significant role in Fas DD-FADD interaction, supporting our in vitro and in vivo
138             The effect of sevoflurane on Fas DD-FADD interaction was examined using fluorescence reso
139  with ERT2 and two degradation domains (FKBP-DD, DHFR-DD), in multiple orientations, and determined (
140 wed that Shld1, the chemical inducer of FKBP-DD, does not interfere with stem cell differentiation, w
141                       We found that the FKBP-DD confers the PB transposase with a higher transpositio
142          In addition, we found that the FKBP-DD regulates transposon activity in a reversible and dos
143                                          For DD methods, EUCAST BPs demonstrated lower susceptibility
144 ated an SNP-based heritability of 20-25% for DD, and observed significant associations of dyslexia ri
145  very major errors (VME) were calculated for DD methods.
146 nsider this gene as a putative candidate for DD.
147 39% of the study sample as indeterminate for DD.
148 ,488 adults underwent 158,119 operations for DD.
149 ing to be the most significant predictor for DD screening.
150  [SD] age, 12.9 [5.1] years); 17 studies for DD, 10 for AD, 8 for OCD, and 1 for PTSD.
151  evaluated as separate or combined tests for DD screening.
152 search that may lead to novel treatments for DD and fibrosis more generally.
153 Calculated degradation rates were slower for DDs and faster for dihydroxylated biphenyls in compariso
154 ere significantly larger (all P < 0.01) for +DD compared to -DD subjects by 1.7-, 2.5-, and 1.9-fold
155 or the photodegradation mechanism that forms DDs and dihydroxylated biphenyls.
156 ith ASD might be etiologically distinct from DD without ASD.
157 to babies with birth weights (BWs) <2,500 g (DD = -11.8, ROR: 0.29, 95% CI: 0.10-0.82, p = 0.020).
158  (WES) with Developmental Disorders G2P (G2P(DD); 2044 entries).
159                                      VEP-G2P(DD) shows a sensitivity/precision of 97.3%/33% for de no
160   In contrast, thioridazine did not generate DD Mtb from starved cells but killed those generated by
161 e describe 15 unrelated individuals who have DD and/or ID, central nervous system (CNS) dysfunction,
162         UCTs had a protective effect on HAZ (DD = +0.25 z-scores, 95% confidence interval [CI]: 0.01-
163                                       Hence, DD-treated cells utilized transcriptional and mRNA stabi
164                Patients with low ML and high DD demonstrated a hyperfibrinolytic biomarker profile, l
165    Conversely, patients with low ML but high DD levels are severely injured, functionally coagulopath
166 aumatic brain injury and had a 7-fold higher DD level (died vs. survived: 103,170 vs. 13,672 ng/mL, P
167 -BR, wet-dry hulling-WD, and dry-dry hulling-DD) and a standard roasting treatment.
168 Additionally, we identify three candidate ID/DD-associated genes of which two have an established rol
169 l disability and developmental disorders (ID/DD) and successfully identify 15 genes with clustering m
170  Response to placebo is large, especially in DD.
171                               Improvement in DD grade at 30 days was associated with improvement in s
172                               Improvement in DD grade/grade 1 DD at 30 days post-TAVR was seen in 70.
173                               Improvement in DD grade/grade 1 DD at 30 days was protective for 1-year
174 acteraceae-affiliated sequences increased in DD tissues, suggesting opportunistic proliferation of th
175 neral population, in which mean ACE level in DD carriers is approximately twice that in II carriers,
176 ) of 44%, higher than previously reported in DD liposarcoma.
177   We also showed that 12% of the variance in DD was accounted for by genotype and that the genetic si
178  larger (all P < 0.04) by up to 8.5-fold in +DD compared to -DD subjects.
179 ficantly larger ( P = 0.012) by 1.4-fold in +DD compared to -DD subjects.
180 ess to DD-CIK of 6 months or less, including DD-CIKs increases the number of transplants by at least
181  grade 3 DD, and 51 (4.1%) had indeterminate DD grade.
182 consensus diagnosis of normal/indeterminate, DD with reduction, or DD without reduction.
183 8, p = 0.048) and household food insecurity (DD = -10.7 pp, ROR: 0.63, 95% CI: 0.43-0.91, p = 0.016).
184  Forty-seven subjects were categorized into +DD ( n = 29) and -DD ( n = 18) groups.
185  CI: 1.32-2.62, p < 0.001) and physical IPV (DD = -7.9 pp, ROR: 0.60, 95% CI: 0.36-0.99, p = 0.048).
186 rall ubiquitination pattern of RIPK1 and its DD-mediated interactions with other DD-containing protei
187 1 activation is known to be regulated by its DD-mediated interaction and ubiquitination, though under
188 or (DD) kidneys as chain-initiating kidneys (DD-CIK) in a kidney paired donation pool (KPDP), and est
189 ffects were also found on women's knowledge (DD = +14.8, ROR: 1.86, 95% CI: 1.32-2.62, p < 0.001) and
190  construct that encodes the Lhx2-HD and Ldb1-DD (dimerization domain) in a single transcript cell-aut
191      Patients presenting with low ML and low DD levels have low injury severity and normal outcomes.
192 C, including PlsX and KASII (FA metabolism), DD-transpeptidase and MurB (peptidoglycan synthesis), gl
193  compare cefiderocol disk diffusion methods (DD) to broth microdilution (BMD) for AST of Gram-negativ
194                       Other genes modulating DD respecification such as lin-14, irx-1, and oig-1 are
195 e that m154 uses its cytoplasmic tail motif, DD, to interfere with the adaptor protein-1 (AP-1) compl
196                  DD was considered negative (DD-) if <500 ng/mL.
197 e such tool, GeneMatcher, we identified nine DD- and/or ID-affected probands with a rare, heterozygou
198                                     Notably, DD is the basic unit of assortativity.
199                               Application of DD-SRM to human serum and tissue provides precise quanti
200 te the different clinical characteristics of DD and schizophrenia (SZ), antipsychotics are deemed equ
201 xample, we predict that, within the class of DD motor neurons, only three (DD04, DD05, or DD06) shoul
202 niform, reliable, and accurate definition of DD for epidemiologic studies is needed.
203  concordance of 4 established definitions of DD in the Coronary Artery Risk Development in Young Adul
204  and clinical factors and the definitions of DD.
205 line joint-specific soft tissue diagnoses of DD, 598 (76%) joints showed no change; 109 (14%) demonst
206 als with a surgically validated diagnosis of DD from the UK, with replication in British, Dutch, and
207 ignificant increases in the zone diameter of DD testing for isolates that were fosA positive compared
208  BET performance regarding the evaluation of DD, with a sensitivity of 86%, specificity of 67%, PPV o
209 whether they contribute to the generation of DD Mtb or kill them.
210    Patients with improvement in >=1 grade of DD/grade 1 DD had reduced 1-year CV death/rehospitalizat
211               Incremental baseline grades of DD were associated with an increase in combined 1- and 2
212 gest genome-wide association study (GWAS) of DD to date.
213                                Within 3 h of DD exposure, Lhcf2 mRNA levels and transcription were st
214 ate significant variability in prevalence of DD and its association with established risk factors acr
215                                Prevalence of DD ranged from 2% to 32% across the 4 definitions, with
216               We evaluated the prevalence of DD using previously published definitions in a populatio
217 over is associated with lower probability of DD downstream.
218 y genotype and that the genetic signature of DD overlapped with attention-deficit/hyperactivity disor
219  was to assess the longitudinal stability of DD and DJD among 401 subjects.
220 rs (SNRIs), and placebo for the treatment of DD, AD, OCD, and PTSD in children and adolescents.
221  weeks of SD therapy, followed by 4 weeks of DD therapy, and 4 weeks after return to SD therapy.
222                                     Based on DD connectivity, we illustrate the close similarity, and
223                             A model based on DD-SIMCA was also developed and applied to the control o
224  and appears to be dispensable in equinox or DD conditions.
225 ney graft and patient survival than LD-KA or DD-KA recipients.
226 ID from mothers of children with ASD-noID or DD suggests that the intellectual disability associated
227  normal/indeterminate, DD with reduction, or DD without reduction.
228  and its DD-mediated interactions with other DD-containing proteins.
229                                     Overall, DD is a local measure that is simple to define, easy to
230                                     Overall, DD surgery performed in England was safe; however, re-op
231                                    Oxacillin DD tests using the Clinical and Laboratory Standards Ins
232                                    Oxacillin DD yielded high ME rates (20.7 to 21.7%) using CLSI or E
233      Our findings demonstrate that oxacillin DD tests using the CLSI M100-S28 breakpoints for S. pseu
234                          Compared to SPK,P+, DD-KA, or LD-KA recipients had significantly higher risk
235 efective p27pT157pT198 phosphomimetic (p27CK-DD), cJun is activated and interacts with p27, and p27/c
236 roduce platelet-derived growth factor (PDGF)-DD, which promotes cellular proliferation, epithelial-me
237                                         PDGF-DD engagement of NKp44 triggered NK cell secretion of in
238   Thus, while cancer cell production of PDGF-DD supports tumor growth and stromal reaction, it concom
239 s and innate lymphoid cells, recognizes PDGF-DD.
240 equential BET is a low cost, well-performing DD screening tool, appropriate to the Primary Care Setti
241 hine learning based algorithm for type I PKS DD affinity and pathway prediction.
242 t a high efficiency tool, (ii) the predicted DD affinity is represented by a probability (0-1), which
243  Cell body peptidoglycan contained primarily DD-crosslinks between meso-diaminopimelic acid and D-ala
244 apted to co-express, from the same promoter, DD-Cas9 with any other gene of interest without co-modul
245                         Of several published DD criteria, it is unclear which, if any, are applicable
246 ed child morbidity 2 week's prior to report (DD = -3.5 pp, ROR: 0.80, 95% CI: 0.56-1.14, p = 0.214) b
247 of animal source foods (ASFs) (respectively, DD = +4.5 pp, ROR: 2.24, 95% CI: 1.09-4.61, p = 0.029 an
248 with 25% exhibiting grade III/IV restrictive DD with mitral regurgitation.
249 were obtained.Measurements and Main Results: DD therapy increased trough AAT levels to normal and, co
250        Here we show that K627 in human RIPK1-DD and its equivalent K612 in murine RIPK1-DD is a key u
251 1-DD and its equivalent K612 in murine RIPK1-DD is a key ubiquitination site that regulates the overa
252                            Moreover, we show DD to be an indicator for topological robustness of scal
253 loped an antibody-independent deep-dive SRM (DD-SRM) approach that capitalizes on multidimensional hi
254 rvention arm, but had no impact on stunting (DD = -6.2 percentage points [pp], relative odds ratio [R
255 D MNs, which are divided into two subgroups: DD and VD.
256 > 0.8) with that of the previously suggested DD susceptibility genes KIAA0319, CTNND2, CNTNAP2 and GR
257 ynthesis capacity (DSC) of patients with SZ, DD, other psychotic disorders, and the DSC of healthy su
258 e duration of principal cell discharges than DD EPSPs, enabling GCs to compare contrasting versions o
259                          We hypothesize that DD/DL circuitry can implement the same pattern separatio
260                     These data indicate that DD, SZ, and other psychotic disorders have similar dysre
261 al and conceptual perspective, and show that DD can reveal structural properties that are not obtaine
262 ng synthetic and real networks, we show that DD distribution can be used to distinguish between diffe
263 t DD play different structural roles and the DD distribution is an important network signature.
264 on strength is around 27 +/- 1 M(-1) for the DD.AA complexes in C(6)D(6), whereas it rises to 1820 +/
265 ter in the caudate region of subjects in the DD group (ES = 0.83, corrected p = 0.048), the SZ group
266 cket to facilitate substrate turnover in the DD-CoA binding region of the protein.
267                In addition, we show that the DD subnuclei have complex reciprocal connections with su
268  We consider chains of length 2 in which the DD-CIK gives to a candidate in the KPDP, and that candid
269                                        Thus, DD-SRM holds great promise for precisely measuring extre
270 with compared to women without bilateral TMJ DD.
271 d 3 per month, and delay times for access to DD-CIK of 6 months or less, including DD-CIKs increases
272      Of the agents tested, rifamycins led to DD Mtb generation, an effect lacking in a rifampin-resis
273 d profiles of HD tissues was more similar to DD tissues than to HH tissues, reflecting a colony-wide
274 jects strongly to DDi, with lesser inputs to DDs and DDmg.
275 fy the contribution of splicing mutations to DDs.
276 y larger (all P < 0.01) for +DD compared to -DD subjects by 1.7-, 2.5-, and 1.9-fold for day, night,
277  0.04) by up to 8.5-fold in +DD compared to -DD subjects.
278 ( P = 0.012) by 1.4-fold in +DD compared to -DD subjects.
279 han that of hydrogel-incorporated unmodified DDs.
280                                        The V(DD)J recombination is currently viewed as an aberrant an
281 alian genomes, thus demonstrating that the V(DD)J recombination is not a "bug" but an important featu
282 e V(D)J recombination fails to explain the V(DD)J recombination, the molecular mechanism of tandem D-
283 e identified 81 loci (66 novel) for vertical DD.
284 or well-differentiated/de-differentiated (WD/DD) liposarcomas has been reported to be minimal, howeve
285 ics in patients with retroperitoneal (RP) WD/DD liposarcoma treated at The University of Texas MD And
286          We provide an explanation as to why DD can characterize structural heterogeneity in mixing p
287  for hemEFS (hazard ratio, 2.1 and 3.1) with DD and DVD.
288 ADD-RS (either ADD-RS=0 or ADD-RS </=1) with DD may be considered to standardize diagnostic rule out
289 rdiac organ responses were noted in 22% with DD and 26% with DVD after 6 months.
290 ation of pretest probability assessment with DD testing is feasible, but the safety and efficiency of
291 ted patients, 35 (38.9%) were diagnosed with DD according to Rome IV criteria, mainly female (n = 30,
292                              Use of EVD with DD increased the detection of positive section margins i
293 ical characteristics, usefulness of EVD with DD, and turnaround times (TATs).
294 psy processing with the practice of EVD with DD.
295 red an adverse factor for OS and hemEFS with DD, whereas translocation t(11;14) was associated with a
296 arily by the placebo response: patients with DD exhibited significantly larger placebo responses (g =
297 of children with either ASD-noID, those with DD, or GP controls.
298 ed events in 9738 exome sequenced trios with DD-affected probands.
299 ical trials of SSRIs or SNRIs in youths with DD, AD, OCD, or PTSD were included.
300 genic effects of the SVs in individuals with DDs.

 
Page Top